U.S. FDA approves GlaxoSmithKline's HIV drug Tivicay

Reuters: The U.S. Food and Drug Administration said on Monday it has approved GlaxoSmithKline Plc's drug Tivicay to treat the most common strain of HIV, the virus that causes AIDS.

Read article